Voyager Therapeutics Inc
VYGR
Market Cap$163.8M
Close$
$12.45
299% upside
Current Fair Value
299% upsideUndervalued by 299% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $163.80 Million |
|---|---|
| Enterprise Value | $152.13 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.13 |
| Beta | 0.82 |
| Outstanding Shares | 58,349,769 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.04 |
|---|---|
| PEG | -1.17 |
| Price to Sales | 3.12 |
| Price to Book Ratio | 0.78 |
| Enterprise Value to Revenue | 2.27 |
| Enterprise Value to EBIT | -2.27 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Voyager Therapeutics Inc
CEO: G. Andre Turenne